Pazobrite 200 Tablet
Prescription Required
Product introduction
Pazobrite 200 Tablet is a protein kinase inhibitor used in the treatment of kidney cancer and soft tissue sarcoma.
Pazobrite 200 Tablet is used to treat different types of cancer
Pazobrite 200 Tablet is used to treat different types of cancer
Uses of Pazobrite Tablet
Benefits of Pazobrite Tablet
In Kidney cancer
Pazobrite 200 Tablet is used to treat kidney cancer and its associated symptoms such as blood in the urine, unexplained low back pain or weight loss, fatigue, loss of appetite, etc. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions. You need to follow your doctor’s instructions very carefully to recover.
In Soft tissue sarcoma
Soft tissue sarcoma is a type of sarcoma that develops in tissues such as bone and muscles. Pazobrite 200 Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Follow your doctor’s instructions carefully and let your doctor know if any of the side effects bother you.
Side effects of Pazobrite Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Pazobrite
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazobrite Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Pazobrite 200 Tablet is to be taken empty stomach.
How Pazobrite Tablet works
Pazobrite 200 Tablet is an anti-cancer medication. It works by binding and inhibiting the enzyme receptors (tyrosine kinase) that are responsible for the proliferation of the cancerous cells. It also restricts the growth of new blood vessels within the tumor. This is how it works against cancer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Pazobrite 200 Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Pazobrite 200 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Pazobrite 200 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Pazobrite 200 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
Pazobrite 200 Tablet is safe to use in patients with kidney disease. No dose adjustment of Pazobrite 200 Tablet is recommended.
Liver
CAUTION
Pazobrite 200 Tablet should be used with caution in patients with liver disease. Dose adjustment of Pazobrite 200 Tablet may be needed. Please consult your doctor.
Use of Pazobrite 200 Tablet is not advised in patients with moderate to severe liver disease.
Use of Pazobrite 200 Tablet is not advised in patients with moderate to severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Pazobrite 200 Tablet
₹173.7/Tablet
Votrient 200mg Tablet
Glaxo SmithKline Pharmaceuticals Ltd
₹289.5/tablet
67% costlier
Pazoci 200 Tablet
Cipla Ltd
₹159.87/tablet
8% cheaper
Pazliz 200 Tablet
Khandelwal Laboratories Pvt Ltd
₹188/tablet
8% costlier
Pazib 200mg Tablet
Glenmark Pharmaceuticals Ltd
₹66.67/tablet
62% cheaper
Pazolit 200mg Tablet
Sun Pharmaceutical Industries Ltd
₹106.17/tablet
39% cheaper
Fact Box
Chemical Class
Alkyldiarylamines Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Tyrosine kinase inhibitors
Patient concerns
FAQs
Is Pazobrite 200 Tablet a chemotherapy medicine?
Pazobrite 200 Tablet is not a conventional chemotherapy medicine. It belongs to a class of medicine called a protein kinase inhibitor. Pazobrite 200 Tablet works by preventing the activity of proteins that are involved in the growth and spread of cancer cells.
How should I take Pazobrite 200 Tablet?
Pazobrite 200 Tablet should be taken orally by mouth once a day or as directed by your doctor. Swallow the tablets whole with water, do not break or crush the tablets. This affects the way the medicine is absorbed and may increase the chance of side effects.
Can Pazobrite 200 Tablet be taken with food?
Pazobrite 200 Tablet should be taken on an empty stomach, at least 1 hour before or 2 hours after food. If it is taken with food, the dosage may need to be increased. Doing this will in turn cause more side effects.
How will I know if Pazobrite 200 Tablet is helping me?
The duration for which you have to continue taking Pazobrite 200 Tablet varies from person to person. The doctor monitors you closely and will be able to better estimate how long the medicine needs to be taken. Do not stop taking it without telling your doctor. It needs to be taken as long as it is effective and you can tolerate it.
Are there any food restrictions while I’m taking Pazobrite 200 Tablet?
Yes, it is best to avoid grapefruit and grapefruit juice while on Pazobrite 200 Tablet, as it may affect how the medicine works in your body. Ask your doctor about any additional foods you should avoid.
How long I have to take Pazobrite 200 Tablet?
The duration for which you have to continue taking Pazobrite 200 Tablet varies from person to person. The doctor monitors you closely and will be able to better estimate how long the medicine needs to be taken. Do not stop taking it without telling your doctor. It needs to be taken as long as it is effective and you can tolerate it.
What is the most important information I need to know about Pazobrite 200 Tablet?
Pazobrite 200 Tablet may cause severe or life-threatening liver damage. Inform your doctor if you have or had liver disease. If you experience any of the following symptoms such as discoloration of the skin or eyes (yellowing), dark urine, extreme tiredness, nausea, vomiting, loss of appetite, pain in the upper right part of the stomach, or unusual bleeding or bruising, call your doctor immediately. Your doctor may ask you to take some lab tests before you start taking Votrient. After you start taking Votrient, you may need to take those lab tests at weeks 3, 5, 7 and 9 and then at months 3 and 4. Your doctor may also prescribe additional tests if necessary. Periodic testing should then continue after 4 months.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1072-73.
- Pazopanib. Research Triangle Park, North Carolina: GlaxoSmithKline; 2009 [revised Apr. 2012]. [Accessed 24 Jan. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: Torrent Pharmaceuticals Ltd
Address: Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹5211
Inclusive of all taxes
30.0 tablets in 1 bottle
SOLD OUT
Variants (2)
Notify me